Back
Day Range
$438.42
$449.14
52-Week Range
$265.00
$615.00
Volume
197,756
50D / 200D Avg
$468.57
/
$437.29
Prev Close
$447.72
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -35.4 | 0.4 |
| P/B | 16.9 | 2.9 |
| ROE % | -42.5 | 3.7 |
| Net Margin % | -30.1 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.6 | 0.2 |
Analyst Price Target
Hold
$705.67
+58.6%
Low: $527.00
High: $964.00
Forward EPS
-$4.49
Est. Revenue
1.5 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$70.33
$59.58 – $79.31
|
4.9 B | 4 |
| FY2029 |
$49.53
$41.96 – $55.85
|
3.9 B | 4 |
| FY2028 |
$31.37
$16.07 – $49.15
|
3 B | 11 |
Key Takeaways
Negative free cash flow of -190.02M
Capital efficient — spends only 0.05% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)432.05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-42.49%
ROIC-23.52%
Net Margin-30.08%
Op. Margin-31.31%
Safety
Debt / Equity
0.59
Current Ratio4.01
Interest Coverage-13.45
Valuation
P/E Ratio
-35.41
P/B Ratio16.94
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 432.05% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 958.40M | Net Income (TTM) | -288.28M |
| ROE | -42.49% | ROA | -22.89% |
| Gross Margin | 94.14% | Operating Margin | -31.31% |
| Net Margin | -30.08% | Free Cash Flow (TTM) | -190.02M |
| ROIC | -23.52% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.59 | Current Ratio | 4.01 |
| Interest Coverage | -13.45 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -35.41 | P/B Ratio | 16.94 |
| P/S Ratio | 10.65 | PEG Ratio | 1.10 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 10.21B | Enterprise Value | 10.36B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 958.40M | 180.13M | 0.0 | 0.0 | 0.0 |
| Net Income | -288.28M | -465.89M | -373.63M | -295.35M | -241.85M |
| EPS (Diluted) | -12.85 | -21.90 | -19.99 | -17.23 | -14.63 |
| Gross Profit | 902.26M | 173.90M | 0.0 | 0.0 | 0.0 |
| Operating Income | -300.10M | -497.88M | -380.50M | -293.57M | -242.48M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.26B | 1.04B | 640.55M | 362.57M | 273.33M |
| Total Liabilities | 656.90M | 287.86M | 235.21M | 165.18M | 77.23M |
| Shareholders' Equity | 602.69M | 754.38M | 405.33M | 197.39M | 196.11M |
| Total Debt | 354.36M | 119.57M | 117.19M | 49.89M | 797,000.0 |
| Cash & Equivalents | 198.69M | 100.02M | 99.92M | 331.55M | 36.27M |
| Current Assets | 1.25B | 1.03B | 637.28M | 361.37M | 271.68M |
| Current Liabilities | 310.29M | 169.28M | 118.55M | 115.89M | 76.84M |